A recent study by the US Centers for Disease Control and Prevention (CDC) warns of the increased risk of infection, hospitalization and death that unvaccinated individuals have with the Delta variant.
Moderna's vaccine is the most effective in preventing hospitalizations, says the same body People who have not had the Covid-19 vaccine or who do not have the full vaccination course are at 11 times more likely to die after being infected with the Delta variant.
The conclusion comes from a recent study by the US Centers for Disease Control and Prevention (CDC), presented on Friday, that looked at Covid-19 infections, hospitalizations and deaths in 13 US states during the months of April and June of this year, period in which the Delta variant gained scale in the country.
The data collected has now been shared and further reveals that the risk of infection with the Delta variant is 4.5 times higher among unvaccinated people and the probability of developing serious illness after infection and being hospitalized is also ten times higher in those who do not have one. or the two doses of the Covid-19 vaccine.
Although the study finds that the vaccination maintained high protection against Covid-19, it highlights a slight loss of effectiveness in preventing infection against the Delta variant.
However, the call for vaccination remains: “Being vaccinated protects against serious Covid-19 diseases, including the Delta variant,” the organism writes on its website, warning that Covid-19 incidence monitoring “by health status vaccination may provide early signs of potential changes in vaccine efficacy that can be confirmed through robust controlled studies.”
Moderna’s is most effective in preventing hospitalization The Centers for Disease Control and Prevention presented another study related to Covid-19 in which it claims that Moderna's vaccine is more effective in preventing hospitalizations than the Pfizer-BioNTech and Johnson & Johnson vaccines. The study in question was based on the analysis of 32,000 patients assisted in hospitals and departments and clinics with emergency services between June and early August in nine US states.
The three vaccines have a high average of hospitalization prevention at around 86%, but it is when you evaluate one by one that you notice the differences.
According to data collected by the CDC, Moderna's vaccine is 95% effective in reducing the risk of hospitalization, while at Pfizer-BioNTech and Johnson & Johnson the efficacy is 80% and 60%, respectively. According to The Washington Post, this second CDC study reinforces the conclusion of a small Mayo Clinic Health System study (not yet peer-reviewed) that Moderna's vaccine is more effective than Pfizer-BioNTech at the time of prevent infections with the Delta variant of SARS-CoV-2.
A third CDC study, which looked at patients at five US hospitals between February and August, also presented on Friday, reveals that mRNA vaccines were 87% effective in preventing hospitalizations and remained highly effective even during the predominance of the Delta variant.
Adapted from: https://visao.sapo.pt/visaosaude/2021-09-13-variante-delta-risco-de-mort...
